Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Neonatal thromboembolism.

Ulrike Nowak-Göttl1, Andrea Kosch, Nicole Schlegel

  • 1Pediatric Hematology/Oncology, University Children's Hospital, Münster, Germany. leagottl@uni-muenster.de

Seminars in Thrombosis and Hemostasis
|April 24, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Genomic and transcriptomic analyses of aortic stenosis enhance therapeutic target discovery and disease prediction.

Nature genetics·2025
Same author

Anticoagulant Management After Emergency Surgery or Major Bleeding in Anticoagulated Patients-Results of the Prospective RADOA Registry.

Pharmaceuticals (Basel, Switzerland)·2025
Same author

Distinct Genetic Risk Profile in Aortic Stenosis Compared With Coronary Artery Disease.

JAMA cardiology·2024
Same author

Genotype-Phenotype Relationship among 785 Unrelated White Women with Inherited Congenital Factor VII Deficiency: A Three-Center Database Study.

Journal of clinical medicine·2024
Same author

Clinical Course and Management of Patients with Emergency Surgery Treated with Direct Oral Anticoagulants or Vitamin K Antagonists-Results of the German Prospective RADOA-Registry.

Journal of clinical medicine·2024
Same author

Venous thromboembolism characteristics, treatment and outcomes in young adults: findings from the Registro Informatizado de Enfermedad TromboEmbólica registry.

Journal of thrombosis and haemostasis : JTH·2023
Same journal

Bridging the Gap in Laboratory Monitoring of Extended Half-Life Factor VIII and IX: Can Thrombin Generation Assays Overcome Assay Discrepancies?

Seminars in thrombosis and hemostasis·2026
Same journal

External Quality Assessment for Low Molecular Weight Heparin Monitoring in the Australasia/Asia-Pacific Region.

Seminars in thrombosis and hemostasis·2026
Same journal

Human evolution: between hemorrhage and thrombosis.

Seminars in thrombosis and hemostasis·2026
Same journal

Full- vs Reduced-Dose Direct Oral Anticoagulants for Extended Treatment of Cancer-Associated Thrombosis: A Multicenter Retrospective Cohort Study.

Seminars in thrombosis and hemostasis·2026
Same journal

Too Old for PESI?: Risk Stratification of Octogenarians with Pulmonary Embolism in the Emergency Department.

Seminars in thrombosis and hemostasis·2026
Same journal

Acute Management and Bleeding Outcomes in Pediatric Pulmonary Embolism: A Large Single-Center Retrospective Cohort Study.

Seminars in thrombosis and hemostasis·2026
See all related articles

Neonates and infants face high risks of thrombus formation due to various conditions and genetic factors. Treatment recommendations for pediatric thromboembolism are adapted from adult protocols due to limited clinical trials.

Area of Science:

  • Pediatric Thrombosis
  • Neonatal Coagulation

Background:

  • Infants and neonates are susceptible to thrombus formation from clinical conditions like central line use, cardiac diseases, and genetic prothrombotic defects.
  • Conditions such as congenital nephrotic syndrome, neonatal hemolytic uremic syndrome, and sepsis contribute to elevated thrombin generation.
  • Genetic factors including protein C, protein S, and antithrombin deficiencies, alongside Factor V and II mutations, increase thromboembolic event risk.

Purpose of the Study:

  • To review the causes and risk factors for thrombus formation in neonates and infants.
  • To highlight the challenges in interpreting laboratory results due to age-dependent reference values.
  • To discuss the adaptation of treatment guidelines from adult protocols for pediatric populations.

Main Methods:

Related Experiment Videos

  • Review of clinical conditions and genetic factors associated with pediatric thrombosis.
  • Analysis of challenges in laboratory result interpretation for neonates and infants.
  • Examination of current treatment adaptation strategies for pediatric thromboembolism.

    • Main Results:

    • Numerous clinical and environmental factors elevate thrombin generation in neonates and infants, leading to thrombus formation.
    • Genetic prothrombotic defects are established risk factors for thromboembolic events in this age group.
    • Lack of specific pediatric clinical trials necessitates adapting adult guidelines for treatment.

    Conclusions:

    • Pediatric thromboembolism arises from a combination of clinical conditions and genetic predispositions.
    • Age-specific reference values are crucial for accurate laboratory interpretation.
    • Secondary long-term anticoagulation in pediatric patients requires individualized assessment.